2.39
+0.14(+6.22%)
Currency In USD
Address
2749 East Parleys Way
Salt Lake City, UT 84109
United States of America
Phone
801 990 0520
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
63
First IPO Date
July 15, 2021
| Name | Title | Pay | Year Born |
| Ms. Evguenia Lindgardt M.B.A. | President, Chief Executive Officer & Director | 693,398 | 1975 |
| Dr. Gregory C. Critchfield M.D., M.S. | Executive Director | 19,904 | 1953 |
| Mr. Austin Aerts | Chief Financial Officer | 367,625 | 1988 |
| Mr. Robert G. Harrison | Chief Information Officer | 384,178 | 1966 |
| Mr. Benjamin G. Jackson J.D. | General Counsel | 410,755 | 1980 |
| Dr. John J. Boniface Ph.D. | Chief Scientific Officer | 431,282 | 1963 |
| Dr. Paul Kearney Ph.D. | Chief Data Officer | 468,734 | 1969 |
| Mr. Lee Anderson | Chief Commercial Officer | 0 | N/A |
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.